APPSWE-Tau Publications

APPSWE-Tau Model Page

Filter publications by application: All Alzheimer's Neuroscience
Filter publications by model type: All Humanization

Author(s)

(Date)

Paper Title

Citation

Model Type

Applications

Full Text

Bitner RS, et al.
Mouse over for full list
Bitner RS, Markosyan S, Nikkel AL, Brioni JD
(2011) In-vivo histamine H3 receptor antagonism activates cellular signaling suggestive of symptomatic and disease modifying efficacy in Alzheimer's disease. Neuropharmacology 60(2-3):460-6
Neuroscience, Alzheimer's
Saydoff JA, et al.
Mouse over for full list
Saydoff JA, Olariu A, Sheng J, Hu Z, Li Q, Garcia R, Pei J, Sun GY, von Borstel R
(2013) Uridine prodrug improves memory in Tg2576 and TAPP mice and reduces pathological factors associated with Alzheimer's disease in related models. J. Alzheimers Dis. 36(4):637-57
Neuroscience, Alzheimer's
Fukuhara K, et al.
Mouse over for full list
Fukuhara K, Ohno A, Ota Y, Senoo Y, Maekawa K, Okuda H, Kurihara M, Okuno A, Niida S, Saito Y, Takikawa O
(2013) NMR-based metabolomics of urine in a mouse model of Alzheimer's disease: identification of oxidative stress biomarkers. J Clin Biochem Nutr 52(2):133-8
Neuroscience, Alzheimer's
Yuzwa SA, et al.
Mouse over for full list
Yuzwa SA, Shan X, Jones BA, Zhao G, Woodward ML, Li X, Zhu Y, McEachern EJ, Silverman MA, Watson NV, Gong CX, Vocadlo DJ
(2014) Pharmacological inhibition of O-GlcNAcase (OGA) prevents cognitive decline and amyloid plaque formation in bigenic tau/APP mutant mice. Mol Neurodegener 9:42
Neuroscience, Alzheimer's
Goncalves MB, et al.
Mouse over for full list
Goncalves MB, Clarke E, Hobbs C, Malmqvist T, Deacon R, Jack J, Corcoran JP
(2013) Amyloid β inhibits retinoic acid synthesis exacerbating Alzheimer disease pathology which can be attenuated by an retinoic acid receptor α agonist. Eur. J. Neurosci. 37(7):1182-92
Neuroscience, Alzheimer's
Lewis J, et al.
Mouse over for full list
Lewis J, Dickson DW, Lin WL, Chisholm L, Corral A, Jones G, Yen SH, Sahara N, Skipper L, Yager D, Eckman C, Hardy J, Hutton M, McGowan E
(2001) Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293(5534):1487-91
Neuroscience, Alzheimer's
Sahara N, et al.
Mouse over for full list
Sahara N, Vega IE, Ishizawa T, Lewis J, McGowan E, Hutton M, Dickson D, Yen SH
(2004) Phosphorylated p38MAPK specific antibodies cross-react with sarkosyl-insoluble hyperphosphorylated tau proteins. J. Neurochem. 90(4):829-38
Neuroscience, Alzheimer's
Ishizawa T, et al.
Mouse over for full list
Ishizawa T, Sahara N, Ishiguro K, Kersh J, McGowan E, Lewis J, Hutton M, Dickson DW, Yen SH
(2003) Co-localization of glycogen synthase kinase-3 with neurofibrillary tangles and granulovacuolar degeneration in transgenic mice. Am. J. Pathol. 163(3):1057-67
Humanization
Neuroscience, Alzheimer's